606
Views
6
CrossRef citations to date
0
Altmetric
Research Article

In vitro–in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream

, , &
Pages 1372-1377 | Received 24 Apr 2012, Accepted 01 Aug 2012, Published online: 12 Oct 2012
 

Abstract

Background: To investigate the relationship between dermatopharmacokinetic (DPK) tape stripping from in vitro and in vivo using 1% terbinafine hydrochloride topical cream as the model formulation.

Methodology: In vitro and in vivo tape strippings were conducted on separated pig ear skin used as a biological membrane for franz diffusion cell testing and the non-hairy skin area at the ventral forearms of healthy volunteers, respectively. Terbinafine (1%) topical cream was applied to the skin for 0.5, 2, and 4 h. The drug profiles of terbinafine across the stratum corneum were determined immediately (time 0 h), and at 0.5, 1, 2, and 4 h after removing the formulation. The amounts of terbinafine were analyzed by a validated high-performance liquid chromatography-ultraviolet method. The area under the curve (AUC) and the maximum amounts of terbinafine absorption (Qmax) were obtained from pharmacokinetic software. Partition coefficient (KSC/veh) and diffusion parameter (D/L2) were derived from the Fick’s second law equation. During the schedule time of 8 h, the deviations of in vitro and in vivo data were 6.61 and 30.46% for AUC and Qmax, respectively. There was insignificant difference of the KSC/veh and the D/L2 between excised pig ear and human skin. In addition, KSC/veh and D/L2 at Tmax of 2 h were used to predict the AUC presented the value of 4.7481 %h whereas the true value calculated from pharmacokinetic software provided the value of 5.9311 %h differing from each other in approximate of 20%.

Conclusions: In vitro tape stripping using the separated pig ear skin as a viable membrane of the franz diffusion cell testing demonstrates the potential to represent in vivo tape stripping in human for topical bioavailability/bioequivalence study of terbinafine hydrochloride 1% topical cream.

Acknowledgment

The authors gratefully acknowledge The 60th Year Supreme Reign of his Majesty King Bhumibol Adulyadej Scholarship, granted by the Faculty of Graduate Studies Academic Year 2009, Mahidol University for financial support. We also thank to Medica Innova Co., Ltd. for providing chemical substances.

Declaration of interest

The authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.